International Tuberculosis Research Center

Recent papers from International Tuberculosis Research Center

1. Analytical and Clinical Performance of the STANDARD M10 MTB/NTM Assay for Detection of Mycobacterium tuberculosis and Nontuberculous MycobacteriaJournal of Experimental & Biomedical Sciences/Biomedical Science Letters · 2026
2. The impact of subtotal pancreatectomy on people with congenital hyperinsulinism and their caregiversFrontiers in Endocrinology · 2026
3. Synthesis of 4-Aminoindole-Containing Cephalosporin Prodrugs and Their Biological Activity against Mycobacterium tuberculosisACS Infectious Diseases · 2026
4. Integrated analysis of miRNA and transcription factor gene expression profiles associated with anti-tuberculosis treatment responsesBMC Infectious Diseases · 2026
5. Evaluation of the laboratory performance of MolecuTech®REBA MTB-MDR kit for the detection of multidrug resistant tuberculosisJournal of Clinical Tuberculosis and Other Mycobacterial Diseases · 2026
6. Impact of vitamin D deficiency on 6-month culture conversion in nontuberculous mycobacterial pulmonary disease.2026
7. Mycobacterium avium : Diversity, Clinical Significance, Old and New Targeted MedicinesACS Infectious Diseases · 2026
8. High efficacy of BPaL among patients infected with Mycobacterium tuberculosis lineage 1 in the PhilippinesIJTLD OPEN · 2026
9. Diagnostic Performance of the STANDARD M10 MTB-RIF/INH Assay for Detection of Mycobacterium tuberculosis and Drug Resistance in Clinical SpecimensJournal of Experimental & Biomedical Sciences/Biomedical Science Letters · 2026
10. Whole-Genome Sequencing and Phenotypic Drug Susceptibility Testing of Bedaquilin, Delamanid, Pretomanid, and Linezolid in Drug-Resistant Mycobacterium tuberculosis from a Single Institute in South KoreaPathogens · 2026
11. Association between nutritional status and clinical characteristics in nontuberculous mycobacterial pulmonary disease: preliminary results from the NTM-KOREA cohortRespiratory Research · 2026
12. Relapse and Emergent Resistance With Novel Short-Course Regimens for Multidrug-Resistant Tuberculosis, United States, 2022–2024Open Forum Infectious Diseases · 2025
13. Whole-Genome and Targeted Sequencing of 75 Drug-Resistant Mycobacterium tuberculosis Clinical Isolates in South KoreaAnnals of Laboratory Medicine · 2025
14. Laboratory strengthening strategies to advance drug susceptibility testing for BPaL regimens in TB treatmentPublic Health Action · 2025
15. From dependence to self-reliance: The future of the global tuberculosis responsePLoS Medicine · 2025
16. BACES score: a predictor of health-related quality of life and associated factors in patients with nontuberculous mycobacterial pulmonary diseaseScientific Reports · 2025
17. Trehalose catalytic shift inherently enhances phenotypic heterogeneity and multidrug resistance in Mycobacterium tuberculosisNature Communications · 2025
18. A methodological review of patient healthcare-seeking journeys from symptom onset to receipt of careBMJ Global Health · 2025
19. Treatment success rate and time to culture conversion under a prospective BPaL cohort studyIJTLD OPEN · 2025
20. Comparison of the Histopathological Observation in Pulmonary Tuberculosis between Elk (Cervus canadensis) Naturally Infected with Mycobacterium bovis and Human with Mycobacterium tuberculosisJournal of Tuberculosis Research · 2025